$27.08
0.02%
NYSE, Jan 02, 10:00 pm CET
ISIN
US5004723038
Symbol
PHG

Royal Philips NV Sponsored ADR Stock price

$27.07
-1.16 4.11% 1M
+2.55 10.40% 6M
-0.01 0.04% YTD
+2.09 8.37% 1Y
+13.19 95.10% 3Y
-24.49 47.50% 5Y
+4.39 19.35% 10Y
-1.12 3.96% 20Y
NYSE, Closing price Fri, Jan 02 2026
-0.01 0.04%

Key metrics

Basic
Market capitalization
$25.9b
Enterprise Value
$33.6b
Net debt
$7.7b
Cash
$2.1b
Shares outstanding
951.0m
Valuation (TTM | estimate)
P/E
135.4 | 16.0
P/S
1.2 | 1.2
EV/Sales
1.6 | 1.6
EV/FCF
66.1
P/B
2.1
Dividends
DPS
$0.97
Yield 1Y | 5Y
3.6% | 1.8%
Growth 1Y | 5Y
100.0% | -
Payout 1Y | 3Y
-109.9% | -28.1%
Increased
1 Year
Financials (TTM | estimate)
Revenue
$20.9b | $21.2b
EBITDA
$3.5b | $3.4b
EBIT
$1.3b | $2.2b
Net Income
$190.0m | $1.6b
Free Cash Flow
$508.9m
Growth (TTM | estimate)
Revenue
-1.5% | 0.3%
EBITDA
204.2% | 24.2%
EBIT
476.2% | 96.6%
Net Income
138.5% | 295.8%
Free Cash Flow
-61.8%
Margin (TTM | estimate)
Gross
43.9%
EBITDA
16.9% | 16.1%
EBIT
6.1%
Net
0.9% | 7.6%
Free Cash Flow
2.4%
Financial Health
Equity Ratio
41.4%
Return on Equity
-5.9%
ROCE
5.7%
ROIC
1.1%
Debt/Equity
0.8
More
EPS
$0.2
FCF per Share
$0.5
Short interest
0.1%
Employees
67k
Rev per Employee
$320.0k
Show more

Is Royal Philips NV Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Royal Philips NV Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

15x Buy
56%
12x Hold
44%

Analyst Opinions

27 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

Buy
56%
Hold
44%

Financial data from Royal Philips NV Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
20,938 20,938
2% 2%
100%
- Direct Costs 11,758 11,758
5% 5%
56%
9,180 9,180
4% 4%
44%
- Selling and Administrative Expenses 5,908 5,908
2% 2%
28%
- Research and Development Expense 2,068 2,068
2% 2%
10%
3,546 3,546
204% 204%
17%
- Depreciation and Amortization 2,267 2,267
51% 51%
11%
EBIT (Operating Income) EBIT 1,279 1,279
476% 476%
6%
Net Profit 190 190
138% 138%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Royal Philips NV Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Royal Philips NV Sponsored ADR Stock News

Positive
Seeking Alpha
12 days ago
Philips N.V. (PHG) is rated a conservative 'Buy' with a maintained price target, reflecting 20%+ annualized upside potential. PHG's leadership in imaging, healthcare AI, and a strong moat in diagnosis and treatment underpin the investment case despite historical missteps. Litigation resolution, productivity initiatives, and a 40–50% dividend payout target support margin expansion and forward ea...
Neutral
GlobeNewsWire
20 days ago
December 15, 2025 Acquisition of SpectraWAVE's next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE's technologies ha...
Neutral
GlobeNewsWire
about one month ago
December 4, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company's previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins...
More Royal Philips NV Sponsored ADR News

Company Profile

Royal Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Head office Netherlands
CEO Roy Jakobs
Employees 66,678
Founded 1891
Website www.philips.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today